Visa amends bylaws to add cure process for director nomination deficiencies

VISA INC.

Board adopted amendments to Amended and Restated Bylaws effective July 22, 2025.
Amendments implement a cure process for certain deficiencies in shareholder director nomination notices.
Company will notify shareholders of deficiencies and allow cure within specified time periods.

Key facts

Extracted from this filing and checked against the source text.

Governance Changes SEC 8-K Item 5.03/5.05/5.06 confidence 0.9

VISA INC.: Amended Bylaws to implement a cure process for certain deficiencies in director nomination notices submitted by shareholders, effective July 22, 2025 (effective 2025-07-22).

Change: bylaw amendment
Effective: 2025-07-22

Exact text from the filing

The Board of Directors of Visa Inc. (the “Company”) amended the Company’s Amended and Restated Bylaws (as amended, the “Bylaws”), effective July 22, 2025. The amendments implement a cure process for certain deficiencies in director nomination notices submitted by shareholders.

View on SEC.gov

Browse all governance changes →

VISA INC. filing history →

Source: SEC EDGAR

accession 0001403161-25-000043

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.